Cabaletta Bio, Inc.
Long

Nice Pattern Developing

Cabaletta Bio is an early stage biotech. Keep an eye on breakout of pattern.
Stock could have huge upside potential due to novel approach of using
CAR-T Cell technology for Auto-Immune disease where as most have used it just for
cancer drugs

Disclaimer